Get started
Author

Shan‐Bing Wang

Observed names: SHAN-BING WANG, Shan-Bing Wang, ShanBing Wang, Shanbing Wang
ORCID: 0000-0002-5897-6829
Observed ORCID: 0000-0002-5897-6829
OpenAlex ID: A5065220615
Continuous use of metformin can improve survival in type 2 diabetic patients with ovarian cancer: A retrospective study
2017 · Shan-Bing Wang, Kai-Jian Lei, et al. · Medicine · 46
The volume of 99mTc sulfur colloid SPET‐defined active bone marrow can predict grade 3 or higher acute hematologic toxicity in locally advanced cervical cancer patients who receive chemoradiotherapy
2019 · Shan‐Bing Wang, Jia‐Pei Liu, et al. · Cancer Medicine · 28
PDF
9MW2821, a nectin-4 antibody-drug conjugate (ADC), in patients with advanced solid tumor: Results from a phase 1/2a study.
2024 · Jian Zhang, Rujiao Liu, et al. · Journal of Clinical Oncology · 21
Single‐photon emission computed tomography‐defined active bone marrow‐sparing volumetric‐modulated arc therapy reduces the incidence of acute hematologic toxicity in locally advanced cervical cancer patients who receive chemoradiotherapy: A single‐center prospective randomized controlled trial
2023 · ShanBing Wang, Jiapei Liu, et al. · Cancer · 12
PDF
Improving prenatal diagnosis with combined karyotyping, CNV-seq and QF-PCR: a comprehensive analysis of chromosomal abnormalities in high-risk pregnancies
2025 · Jia-pei Liu, Shan-Bing Wang, et al. · Frontiers in Genetics · 9
PDF
Significant response of low-dose apatinib monotherapy in brain metastases of triple-negative breast cancer: A case report
2019 · Ting Li, Shan-Bing Wang, et al. · Medicine · 9
Eyelash trichomegaly following treatment with erlotinib in a non-small cell lung cancer patient: A case report and literature review
2015 · SHAN-BING WANG, KAI-JIAN LEI, et al. · Oncology Letters · 9
PDF
Continuous Low-Dose Apatinib Combined With WBRT Significantly Reduces Peritumoral Edema and Enhances the Efficacy of Symptomatic Multiple Brain Metastases in NSCLC
2021 · Yue Ren, Shan-Bing Wang, et al. · Technology in Cancer Research & Treatment · 7
Phase 2 dose-ranging study to evaluate the efficacy and safety of liposomal irinotecan (LY01610) as a second-line treatment for patients with relapsed small cell lung cancer
2024 · Puyuan Xing, Shanbing Wang, et al. · EClinicalMedicine · 6
Efficacy and safety of 9 MW2821, an antibody-drug conjugate targeting Nectin-4 monotherapy, in patients with recurrent or metastatic cervical cancer: A multicenter, open-label, phase I/II study
2024 · Huijuan Yang, Jian Zhang, et al. · Gynecologic Oncology · 4
Complete remission of reactive cutaneous capillary endothelial proliferation caused by the programmed cell death-1 inhibitor camrelizumab achieved through thalidomide monotherapy: A case report
2023 · Chunxiu Wang, Kaijian Lei, et al. · Experimental and Therapeutic Medicine · 4
PDF
SHR-1701 in combination with platinum-based chemotherapy and BP102 (a bevacizumab biosimilar) for persistent, recurrent, or metastatic cervical cancer: Data from a phase 1b/3 study.
2023 · Jihong Liu, Yun Zhou, et al. · Journal of Clinical Oncology · 3
Apatinib‐induced Grade 3 hand‐foot syndrome in advanced lung adenocarcinoma successful treated with thalidomide: A case report
2020 · Yue Ren, Ting Li, et al. · Dermatologic Therapy · 2
PDF
Combined Active Bone Marrow‐Sparing Radiotherapy and Prophylactic PEG ‐ rhG ‐ CSF to Reduce Severe Neutropenia During Platinum‐Doublet Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer: A Phase II Trial
2026 · ShanBing Wang, Jiapei Liu, et al. · Cancer Medicine
PDF
Active bone marrow-sparing to reduce the incidence of grade 3+ acute hematologic toxicity in patients with locally advanced cervical cancer who receive chemoradiotherapy: A single-center prospective randomized controlled trial.
2023 · ShanBing Wang, JiaPei Liu, et al. · Journal of Clinical Oncology
Celecoxib Combined with Thalidomide in the Treatment of Refractory Neoplastic Fever in Advanced Cholangiocarcinoma: A Case Report
2020 · Kaijian Lei, Qiu-yuan Liang, et al. · Journal of Surgical Oncology
Expression of leptin and leptin receptor in esophageal squamous cell carcinoma and its clinical significance
2013 · Shan‐Bing Wang, Yu-min Jia, et al. · 肿瘤研究与临床
Expressions of leptin and lipoprotein α in esophageal squamous cell carcinoma and their clinical significance
2012 · Shuangping Zhang, Shan‐Bing Wang, et al. · 肿瘤研究与临床
Works count: 18
Citation count: 160
H-index: 7
I10-index: 4
Year
Topic
Type